Collegium Pharmaceutical (COLL) Inventory Average (2016 - 2026)

Collegium Pharmaceutical has reported Inventory Average for 11 years, with the latest figure at $78.0 million in Q2 2026.

• On a quarterly basis, Inventory Average rose 107.0% year-over-year to $78.0 million in Q2 2026; TTM through Jun 2026 was $78.0 million, a 107.0% increase from a year earlier, with the FY2025 full-year figure at $38.2 million, up 12.64% from the prior year.
• Inventory Average was $78.0 million for Q2 2026 at Collegium Pharmaceutical, up from $41.8 million in the prior quarter.
• The five-year high for Inventory Average was $79.0 million in Q2 2022, with the low at $29.5 million in Q2 2023.
• Average Inventory Average over 5 years is $43.9 million, with a median of $37.9 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Inventory Average surged 349.99% in 2022, then sank 62.69% in 2023.
• Over 5 years, Inventory Average stood at $55.6 million in 2022, then tumbled by 40.21% to $33.2 million in 2023, then rose by 10.74% to $36.8 million in 2024, then advanced by 7.3% to $39.5 million in 2025, then soared by 97.57% to $78.0 million in 2026.
• The last three Inventory Average figures came in at $78.0 million (Q2 2026), $41.8 million (Q1 2026), and $39.5 million (Q4 2025), per Business Quant data.